Provided by Tiger Fintech (Singapore) Pte. Ltd.

Spruce Biosciences, Inc.

0.1298
-0.0101-7.22%
Post-market: 0.0850-0.0448-34.51%19:59 EDT
Volume:4.64M
Turnover:609.20K
Market Cap:5.48M
PE:-0.10
High:0.1420
Open:0.1420
Low:0.1240
Close:0.1399
Loading ...

BRIEF-Spruce Biosciences Inc - Approves 55% Workforce Reduction - SEC Filing

Reuters
·
26 Apr

Spruce Biosciences Inc - Workforce Reduction Effective Immediately, Termination Date May 2 - SEC Filing

THOMSON REUTERS
·
26 Apr

Spruce Biosciences: Hold Rating Amid Strategic Pipeline Replenishment and Market Uncertainties

TIPRANKS
·
17 Apr

RBC Cuts Price Target on Spruce Biosciences to $0.50 From $1.50, Keeps Sector Perform, Speculative Risk

MT Newswires Live
·
16 Apr

Spruce Biosciences (SPRB) Receives a Hold from RBC Capital

TIPRANKS
·
16 Apr

Crude Oil Moves Lower; Citigroup Posts Upbeat Results

Benzinga
·
16 Apr

Spruce acquires tralesinidase alfa enzyme replacement therapy

TIPRANKS
·
15 Apr

BRIEF-Spruce Biosciences Announces New Corporate Strategy And Acquisition Of Tralesinidase Alfa

Reuters
·
15 Apr

Spruce Biosciences Inc: Expects Its Cash Runway to Fund Its Current Operating Plan Through End of 2025

THOMSON REUTERS
·
15 Apr

Spruce Biosciences Inc - Bla Submission to FDA for Ta-Ert Anticipated in 1H 2026

THOMSON REUTERS
·
15 Apr

Spruce Biosciences Announces New Corporate Strategy and Acquisition of Tralesinidase Alfa for the Treatment of Sanfilippo Syndrome Type B (Mps Iiib)

THOMSON REUTERS
·
15 Apr

Spruce Biosciences Announces New Corporate Strategy and Acquisition of Tralesinidase Alfa for the Treatment of Sanfilippo Syndrome Type B (MPS IIIB)

Business Wire
·
15 Apr

Spruce Biosciences Inc expected to post a loss of 21 cents a share - Earnings Preview

Reuters
·
04 Apr

Spruce Biosciences Delays Annual Report Filing

TIPRANKS
·
01 Apr

Spruce Biosciences Inc expected to post a loss of 21 cents a share - Earnings Preview

Reuters
·
28 Mar

Spruce Biosciences Inc expected to post a loss of 21 cents a share - Earnings Preview

Reuters
·
21 Mar

Spruce Biosciences Inc expected to post a loss of 21 cents a share - Earnings Preview

Reuters
·
14 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
11 Mar

Spruce Biosciences Inc expected to post a loss of 21 cents a share - Earnings Preview

Reuters
·
07 Mar

Spruce Biosciences Appoints Interim Chief Medical Officer

TIPRANKS
·
28 Dec 2024